reduce basal insulin dose when starting glp-1 receptor agonist Titration algorithm for π Insulin Icodec is changing
Description
Most people taking a 1,250 version wont even know they need to tell their doctor
The GLP-1 receptor agonist market is experiencing significant growth, driven by the increasing prevalence of type 2 diabetes and obesity, and the high...
Should a drug with the FDAs most serious warning be this easy to access for 1.4 billion people
GLP-1s claimed the top two spots in 2024 drug spending and accounted for more than one-third of the top 10 drugs overall.
GLP-1 drug interactions may affect medication absorption
